Radiation dose measurement developer VeriTeQ has been awarded a U.S. patent for its wireless molecular sensor system and process.
The patent covers methods and systems for measuring and wirelessly communicating particular molecular levels using an implantable sensor device that can be operated without batteries, VeriTeQ said.
The company plans to use the technology to develop biosensing microchip applications, initially focusing on radiation dose measurement technologies used during cancer treatment.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
